Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Acitretin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Acitretin 10mg capsules
1305020A0AAABAB
|
Acitretin | Acitretin | Skin | 1,423 |
|
Acitretin 25mg capsules
1305020A0AAAAAA
|
Acitretin | Acitretin | Skin | 796 |
|
Neotigason 10mg capsules
1305020A0BBABAB
|
Neotigason | Acitretin | Skin | 70 |
|
Neotigason 25mg capsules
1305020A0BBAAAA
|
Neotigason | Acitretin | Skin | 16 |
|
Acitretin 5mg/5ml oral suspension
1305020A0AAAEAE
|
Acitretin | Acitretin | Skin | 2 |
|
Acitretin 10mg/5ml oral solution
1305020A0AAAFAF
|
Acitretin | Acitretin | Skin | No data available |
|
Acitretin 10mg/5ml oral suspension
1305020A0AAADAD
|
Acitretin | Acitretin | Skin | No data available |
|
Acitretin 5mg/5ml oral solution
1305020A0AAACAC
|
Acitretin | Acitretin | Skin | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.